Ulland Investment Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119K Hold
300
0.09% 93
2026
Q1
$138K Hold
300
0.12% 82
2025
Q4
$170K Hold
300
0.14% 71
2025
Q3
$134K Hold
300
0.1% 77
2025
Q2
$163K Sell
300
-173
-37% -$90.5K 0.12% 70
2025
Q1
$234K Sell
473
-265
-36% -$147K 0.2% 56
2024
Q4
$385K Hold
738
0.25% 42
2024
Q3
$363K Hold
738
0.27% 43
2024
Q2
$328K Hold
738
0.23% 46
2024
Q1
$295K Hold
738
0.24% 44
2023
Q4
$249K Sell
738
-116
-14% -$34.6K 0.25% 48
2023
Q3
$250K Buy
854
+8
+0.9% +$2.5K 0.27% 46
2023
Q2
$289K Hold
846
0.3% 46
2023
Q1
$216K Sell
846
-10
-1% -$2.46K 0.25% 53
2022
Q4
$227K Sell
856
-1,025
-54% -$250K 0.27% 52
2022
Q3
$353K Sell
1,881
-45
-2% -$9.66K 0.39% 42
2022
Q2
$387K Sell
1,926
-520
-21% -$122K 0.4% 44
2022
Q1
$738K Sell
2,446
-14
-0.6% -$4.09K 0.55% 38
2021
Q4
$884K Buy
+2,460
New +$846K 0.56% 37

Other funds holding ISRG

Ulland Investment Advisors's ISRG Position: Q2 2026 in Review

Ulland Investment Advisors held its Intuitive Surgical (ISRG) position steady in Q2 2026 at 300 shares worth $119K. The position accounts for 0.09% of the portfolio, ranked #93.

Ulland Investment Advisors first reported a position in ISRG in Q4 2021 and has held it in 19 quarters since. The position peaked at $884K in Q4 2021. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Ulland Investment Advisors held 300 shares of Intuitive Surgical worth $119K as of Q2 2026.
  • Ulland Investment Advisors left its Intuitive Surgical share count unchanged in Q2 2026.
  • Intuitive Surgical made up 0.09% of Ulland Investment Advisors's portfolio in Q2 2026, its #93 holding.
  • Ulland Investment Advisors first reported a position in Intuitive Surgical in Q4 2021 and has held it in 19 quarters since.
  • Ulland Investment Advisors's Intuitive Surgical position peaked at $884K in Q4 2021.
  • 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.